Author:
van der Pol M A,Feller N,Ossenkoppele G J,Weijers G W D,Westra A H,van Stijn A,Broxterman H J,Schuurhuis G J
Publisher
Springer Science and Business Media LLC
Subject
Oncology,Cancer Research,Hematology
Reference8 articles.
1. San Miguel JF, Martinez A, Macedo A, Vidriales MB, Lopez-Berges C, Gonzalez M et al. Immunophenotyping investigation of minimal residual disease is a useful approach for predicting relapse in acute myeloid leukemia patients. Blood 1997; 90: 2465–2470.
2. Venditti A, Buccisano F, Del Poeta G, Maurillo L, Tamburini A, Cox C et al. Level of minimal residual disease after consolidation therapy predicts outcome in acute myeloid leukemia. Blood 2000; 96: 3948–3952.
3. van der Kolk DM, de Vries EG, Muller M, Vellenga E . The role of drug efflux pumps in acute myeloid leukemia. Leuk Lymphoma 2002; 43: 685–701.
4. van der Pol MA, Broxterman HJ, Pater JM, Feller N, van der Maas M, Weijers GWD et al. Function of the ABC transporters, P-glycoprotein, multidrug resistance protein and breast cancer resistance protein in minimal residual disease in acute myeloid leukemia. Haematologica 2003; 88: 134–147.
5. van der Pol MA, Pater JM, Feller N, Westra AH, van Stijn A, Ossenkoppele GJ et al. Functional characterization of minimal residual disease for P-glycoprotein and multidrug resistance protein activity in acute myeloid leukemia. Leukemia 2001; 15: 1554–1563.
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献